Women who have lipofilling after reconstruction are no more likely to have a recurrence or be diagnosed with a new cancer than women who never had lipofilling.
A study suggests that radiation after implant reconstruction seems to cause more complications than radiation given after autologous reconstruction.
While most women having breast cancer surgery won't develop an infection, research shows that infections after breast surgery happen more often than expected.
Women whose breasts look significantly different from each other after lumpectomy are more likely to be depressed and feel ashamed of their bodies.
Results from a national survey of oncologists and primary care doctors suggest that most cancer survivors are on their own when it comes to survivorship care.
The American Society of Clinical Oncology has developed new guidelines on three problems that cancer survivors often deal with: fatigue, neuropathy, and anxiety and depression.
A study suggests that 1 year after surgery, women who had immediate autologous reconstruction were more satisfied with their breasts than women who had immediate implant reconstruction. Still, women who had autologous reconstruction had more pain than they did before surgery.
A very small study suggests that more than half of women who had mastectomy made a reconstruction decision that didn't align with their goals and preferences.
Older and younger women benefit equally from breast reconstruction; age shouldn't disqualify a woman from having reconstruction.
A study suggests fat grafting breast reconstruction does not increase the risk of breast cancer recurrence compared to more traditional reconstruction techniques.
A Dutch study estimates that for every 7,000 women who get breast implants, one woman will develop anaplastic large-cell lymphoma in the breast by age 75.
A small Dutch study has found that some women having mastectomy may want to bank their nipple so it can be attached later to their reconstructed breast.
A study suggests that silicone breast implants are associated with a higher risk of certain autoimmune disorders, as well as stillbirth and melanoma, but the FDA disagrees with the results.
Women who pick their own surgeons more likely to be treated by more experienced doctors.
Doing a full breast lift after autologous reconstruction may allow women with large or sagging breasts to have nipple-sparing mastectomy.
Decisions about the type of reconstruction a woman has should be personalized to each woman's unique situation and informed by the most current information on long-term outcomes, satisfaction, and complication rates.
Compared to DIEP flap reconstruction and implant reconstruction, latissimus dorsi flap reconstruction caused the greatest loss of shoulder function, strength, and mobility.
A small study found that women who had textured implants for reconstruction after breast cancer surgery had a small but statistically significant increase in the risk of the breast cancer coming back.
Nearly 75% of women surveyed who opted for mastectomy without reconstruction were satisfied with the results, but almost 25% said their decision to go flat was not supported by their surgeons.
The early weeks of the COVID-19 pandemic caused 44% of breast cancer survivors to have a delay in care, according to an online survey.
The FDA has sent warning letters to two breast implant manufacturers because the companies have not conducted the post-approval long-term safety studies that were required as part of the implants' FDA approval.
On July 24, 2019, Allergan announced a global recall of Biocell textured breast implants and tissue expanders after the FDA requested the action.
National Comprehensive Cancer Network treatment guidelines have been developed for breast implant-associated anaplastic large-cell lymphoma, a rare type of cancer linked to textured breast implants.
White women are 24% more likely to have immediate reconstruction than Black women; 26% more likely than Asian, Pacific Islander, and Native American women; and 19% more likely than Hispanic women.